Renalytix (RENX) News Today GBX 11.40 -0.35 (-2.98%) As of 01/21/2025 12:06 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Renalytix Plc (RTNXF)January 7, 2025 | finance.yahoo.comRenalytix Successfully Passes All Resolutions at AGMDecember 20, 2024 | markets.businessinsider.comRenalytix Advances Strategic Goals with Funding and Market ExpansionDecember 19, 2024 | markets.businessinsider.comRenalytix Plc (LON:RENX) Insider Purchases £2,250 in StockDecember 12, 2024 | insidertrades.comRenalytix Leadership Engages in Notable Share TransactionsDecember 12, 2024 | markets.businessinsider.comRenalytix Plc (LON:RENX) Insider Purchases £4,264 in StockDecember 7, 2024 | insidertrades.comRenalytix Appoints Robert Naylor to Boost Strategic GrowthDecember 3, 2024 | markets.businessinsider.comRenalytix Strengthens Leadership with New DirectorDecember 3, 2024 | markets.businessinsider.comRenalytix Releases Annual Report and AGM DetailsNovember 26, 2024 | markets.businessinsider.comRenalytix AI Targets Profitability with Kidney Test SalesNovember 21, 2024 | markets.businessinsider.comRenalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025November 21, 2024 | finanznachrichten.deRenalytix Reports Reduced Losses and Strong Financial OutlookNovember 21, 2024 | markets.businessinsider.comRenalytix PLC Sees Major Voting Rights ShiftNovember 7, 2024 | markets.businessinsider.comRenalytix Sees Major Shift in Voting RightsNovember 7, 2024 | markets.businessinsider.comRenalytix Appoints Julian Baines as Executive ChairmanNovember 5, 2024 | markets.businessinsider.comChristopher H. B. Mills Sells 83,696 Shares of Renalytix Plc (LON:RENX) StockOctober 13, 2024 | insidertrades.comCommencement of trading on OTCQB in the United StatesOctober 8, 2024 | finance.yahoo.comRenalytix (NASDAQ:RNLX) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comRenalytix AI plc (2O9.MU)August 29, 2024 | uk.finance.yahoo.comLatest News for Renalytix Stock (NASDAQ:RNLX)May 28, 2024 | benzinga.comIs Renalytix the best penny stock to buy today?March 9, 2024 | uk.finance.yahoo.comRNLX Mar 2024 2.500 callFebruary 17, 2024 | finance.yahoo.comRenalytix plc: Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024February 15, 2024 | finanznachrichten.deRenalytix AI plc (RENX)February 15, 2024 | uk.investing.comRenalytix Plc (RNLX) stock price, news, quote & history – Yahoo FinanceFebruary 14, 2024 | nz.finance.yahoo.comRenalytix PLC RENXFebruary 13, 2024 | morningstar.comAfter the Renalytix share price jumps 500% in 3 days, is it time to buy?February 13, 2024 | uk.finance.yahoo.comRenalytix plc: New published data demonstrates KidneyIntelX has broad implications for winning war on chronic kidney diseaseJanuary 10, 2024 | finanznachrichten.deRenalytix Stock (NASDAQ:RNLX) Earnings Dates and Earning CallsNovember 15, 2023 | benzinga.comRenalytix Reports Full Year Fiscal 2023 ResultsSeptember 28, 2023 | markets.businessinsider.comRenalytix Appoints Senior Executive Howard Doran as Chief Business OfficerSeptember 7, 2023 | finance.yahoo.comRenalytix Appoints Financial Executive Catherine Coste to its Board of DirectorsJuly 3, 2023 | finance.yahoo.comFDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney DiseaseJune 29, 2023 | finance.yahoo.comKidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific ConferencesJune 15, 2023 | finance.yahoo.comIs the Renalytix share price a bargain or a falling knife?May 31, 2023 | uk.movies.yahoo.comNew Published Real-World Evidence Shows KidneyIntelX(TM) UtilityApril 20, 2023 | marketwatch.comNew Published Real-World Evidence Shows KidneyIntelX™ UtilityApril 19, 2023 | finance.yahoo.comData Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical MeetingApril 12, 2023 | finance.yahoo.comRenalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial ResultsMarch 30, 2023 | finance.yahoo.comRenalytix Shares Fall on Delay to FDA Marketing Authorization Decision on KidneyIntelXMarch 21, 2023 | marketwatch.comRenalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceFebruary 9, 2023 | finance.yahoo.comRenalytix announces a c.$20.3 million private placementFebruary 8, 2023 | finance.yahoo.comRenalytix Shares Rise on $10 Mln Grant Award to Advance Chronic Kidney Disease TreatmentJanuary 26, 2023 | marketwatch.comRenalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United StatesJanuary 26, 2023 | finance.yahoo.comRenalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systemsJanuary 9, 2023 | finance.yahoo.comPrimary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and OutcomesDecember 1, 2022 | finance.yahoo.comRenalytix AI, Inc.: Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023November 30, 2022 | finanznachrichten.deWhat’s going on with the Renalytix share price?November 30, 2022 | msn.comRenalytix plc: Renalytix Reports Full Year Fiscal 2022 ResultsOctober 31, 2022 | finanznachrichten.deRenalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31October 24, 2022 | finance.yahoo.com Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address RENX Media Mentions By Week RENX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENX News Sentiment▼0.000.64▲Average Medical News Sentiment RENX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENX Articles This Week▼00▲RENX Articles Average Week Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kooth News Today Cambridge Cognition News Today Induction Healthcare Group News Today IQ-AI News Today Feedback News Today Craneware News Today Creo Medical Group News Today Redx Pharma News Today e-therapeutics News Today Venture Life Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:RENX) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
